Cross Country Healthcare Crecimiento futuro
Future controles de criterios 3/6
Cross Country Healthcare's revenue is forecast to decline at 6.8% per annum while its annual earnings are expected to grow at 71.5% per year. EPS is expected to grow by 71% per annum. Return on equity is forecast to be 4.3% in 3 years.
Información clave
71.5%
Tasa de crecimiento de los beneficios
71.0%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 20.1% |
| Tasa de crecimiento de los ingresos | -6.8% |
| Rentabilidad financiera futura | 4.3% |
| Cobertura de analistas | Good |
| Última actualización | 21 Oct 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety
Oct 15Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market
Jul 31
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet
Feb 22Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)
Feb 09Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital
Oct 09Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?
Sep 13These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well
Aug 19Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Jun 26At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?
Jun 08Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?
Apr 28Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)
Mar 15Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching
Mar 02If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity
Jan 20Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet
Jan 05Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?
Oct 29Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital
Oct 14Paring My Cross Country Healthcare Gains
Sep 29Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?
Sep 26Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC
Sep 14Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet
Aug 21Cross Country Healthcare rises postmarket on $100M stock buyback program
Aug 16Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided
Aug 03Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?
Jun 16Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 1,335 | 29 | N/A | N/A | 4 |
| 12/31/2025 | 1,306 | 23 | 74 | 82 | 8 |
| 12/31/2024 | 1,349 | -6 | 114 | 123 | 8 |
| 6/30/2024 | 1,575 | 8 | 159 | 171 | N/A |
| 3/31/2024 | 1,776 | 46 | 195 | 208 | N/A |
| 12/31/2023 | 2,020 | 73 | 235 | 248 | N/A |
| 9/30/2023 | 2,234 | 102 | 228 | 241 | N/A |
| 6/30/2023 | 2,428 | 124 | 298 | 311 | N/A |
| 3/31/2023 | 2,641 | 156 | 200 | 210 | N/A |
| 12/31/2022 | 2,807 | 188 | 125 | 134 | N/A |
| 9/30/2022 | 2,819 | 227 | 47 | 56 | N/A |
| 6/30/2022 | 2,558 | 216 | -95 | -87 | N/A |
| 3/31/2022 | 2,136 | 175 | -98 | -90 | N/A |
| 12/31/2021 | 1,677 | 132 | -93 | -86 | N/A |
| 9/30/2021 | 1,252 | 59 | -16 | -10 | N/A |
| 6/30/2021 | 1,071 | 34 | -21 | -16 | N/A |
| 3/31/2021 | 956 | 9 | -20 | -15 | N/A |
| 12/31/2020 | 836 | -13 | 23 | 27 | N/A |
| 9/30/2020 | 836 | -19 | 15 | 20 | N/A |
| 6/30/2020 | 851 | -21 | 10 | 14 | N/A |
| 3/31/2020 | 837 | -58 | 7 | 10 | N/A |
| 12/31/2019 | 822 | -58 | 3 | 6 | N/A |
| 9/30/2019 | 808 | -76 | 7 | 10 | N/A |
| 6/30/2019 | 800 | -74 | 24 | 28 | N/A |
| 3/31/2019 | 801 | -20 | 16 | 21 | N/A |
| 12/31/2018 | 816 | -17 | 16 | 21 | N/A |
| 9/30/2018 | 835 | 31 | 34 | 39 | N/A |
| 6/30/2018 | 863 | 38 | 34 | 38 | N/A |
| 3/31/2018 | 868 | 41 | N/A | 57 | N/A |
| 12/31/2017 | 865 | 38 | N/A | 46 | N/A |
| 9/30/2017 | 868 | 2 | N/A | 27 | N/A |
| 6/30/2017 | 854 | 9 | N/A | 43 | N/A |
| 3/31/2017 | 845 | -13 | N/A | 29 | N/A |
| 12/31/2016 | 834 | 8 | N/A | 30 | N/A |
| 9/30/2016 | 804 | 10 | N/A | 32 | N/A |
| 6/30/2016 | 785 | 1 | N/A | 25 | N/A |
| 3/31/2016 | 778 | 21 | N/A | 21 | N/A |
| 12/31/2015 | 767 | 4 | N/A | 18 | N/A |
| 9/30/2015 | 762 | -10 | N/A | 18 | N/A |
| 6/30/2015 | 756 | -22 | N/A | 7 | N/A |
| 3/31/2015 | 686 | -28 | N/A | 5 | N/A |
| 12/31/2014 | 618 | -32 | N/A | -4 | N/A |
| 9/30/2014 | 539 | -64 | N/A | -6 | N/A |
| 6/30/2014 | 458 | -55 | N/A | -1 | N/A |
| 3/31/2014 | 446 | -54 | N/A | 1 | N/A |
| 12/31/2013 | 438 | -54 | N/A | 9 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: CCRN's forecast earnings growth (71.5% per year) is above the savings rate (2.5%).
Beneficios vs. Mercado: CCRN's earnings (71.5% per year) are forecast to grow faster than the US market (15.4% per year).
Beneficios de alto crecimiento: CCRN's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: CCRN's revenue is expected to decline over the next 3 years (-6.8% per year).
Ingresos de alto crecimiento: CCRN's revenue is forecast to decline over the next 3 years (-6.8% per year).
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: CCRN's Return on Equity is forecast to be low in 3 years time (4.3%).